Hypothalamic-Pituitary-Adrenal Axis Study in Pediatric Subjects With Perennial Allergic Rhinitis

- Female, Maleergic Rhinitis
- Completed

Study Title: Hypothalamic-Pituitary-Adrenal (HPA)-Axis Study in Pediatric Subjects With Perennial Female, Maleergic Rhinitis (PAR)

Teva Identifier: BDP-AR-307

ClinicalTrials.gov Identifier: NCT01697956

Study Status: Completed

Trial Condition(s): Female, Maleergic Rhinitis

Interventions: Drug: BDP | Drug: Placebo

Study Description

Please refer to ClinicalTrials.gov for a description of the trial

Participation criteria and map of study locations

Key Participation Requirements

Gender: Female, Male

Age group: Child

Age Range: 6 Years to 11 Years

Trial Duration: 10/01/2012 - 02/01/2013

Phase: Phase 3

Study Type

Interventional